(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
LATEST POSTS
- 1
Investigate Business Mastercard Choices for Better Rewards and Rewards - 25 Movies That Leaving an Imprint with Inventive Innovation
- 3Nature: 10 High priority Setting up camp Spots In Europe
- 4Vote in favor of your #1 Sort of Convenience for a Family
- 5Step by step instructions to Look at Compact disc Rates: A Thorough Aide
- You finally got a doctor's appointment. Here's how to get the most out of it
- Astonishing Deserts All over The Planet You Really want To Visit
- Soldiers seize power in Guinea-Bissau and detain the president
- L.A.'s most famous midcentury home, the Stahl House, is on the market for the 1st time, at $11K per square foot: See inside
- Putting resources into Yourself: Self-awareness Techniques
- 5 Must-Attempt Fascinating Dishes from Around the World
- Figuring out the Business venture Code: The Response to Building an Effective Startup
- Former 'Bachelorette' welcomes 1st baby via emergency c-section
- What's inside Mexico's Popocatépetl? Scientists obtain first 3D images of the whole volcano
